The mononuclear phagocyte system in hepatocellular carcinoma

Area of Science:

• Immunology
• Oncology
• Hepatology

Background:

• The mononuclear phagocyte system (MPS), comprising monocytes, dendritic cells, and macrophages, is critical for innate immunity against cancer.
• Hepatocellular carcinoma (HCC) is a complex liver cancer influenced by viral infections, metabolic issues, and alcohol, with outcomes depending on liver function, tumor stage, and patient status.
• The tumor microenvironment and innate immune responses, including cytokine regulation of T-cell differentiation, play significant roles in HCC prognosis.

Purpose of the Study:

• To elucidate the function and impairment of the MPS in the context of HCC progression.
• To outline the multifaceted impact of HCC on the MPS.
• To illustrate how HCC influences MPS cell phenotype and cytokine production.

Main Methods:

• This review synthesizes existing research on the interplay between HCC and the MPS.
• It analyzes how HCC affects MPS cell characteristics and their secreted cytokines.
• The review characterizes the functional status and dysregulation of the MPS in HCC patients.

Main Results:

• HCC induces significant remodeling of MPS cell phenotypes.
• HCC alters the production of cytokines by MPS cells, impacting the immune microenvironment.
• The function of the MPS is impaired in the presence of HCC, affecting immune surveillance and response.

Conclusions:

• Elucidating the role of the MPS in HCC is essential for developing novel therapeutic strategies.
• Targeting MPS dysregulation within the tumor microenvironment may enhance HCC treatment efficacy.
• A comprehensive understanding of MPS function in HCC can lead to improved patient prognosis.